Table 2.
Recommendations for ACCP Support of Clinical Pharmacists’ Efforts to Advance Clinical Pharmacogenomics
| Clinical Pharmacogenomics Implementation Science |
| • Curate and disseminate pharmacogenomics implementation science education resources |
| - Endorse the CPIC guidelines together with publicizing new or updated guidelines |
| - Create a resource page on the ACCP website that summarizes pertinent resources and provides links to implementation guides and templates (e.g., IGNITE and CPIC resources) |
| - Provide webinars from content experts related to implementation strategies (e.g., budget impact analysis, engaging key stakeholders), clinical informatics, and quantitation of operational metrics |
| • Promote and support the development of short “sabbaticals” or traineeships at sites implementing pharmacogenomics clinical services to provide hands-on training |
| • Engage with other professional organizations to advocate the clinical pharmacist’s role in providing pharmacogenomics services |
| - For gene-drug pairs with strong evidence warranting implementation, jointly advocate reimbursement of pharmacogenomics testing |
| - Advocate reimbursement of medication optimization that includes cognitive services for interpreting and applying pharmacogenomics results |
| Clinical Pharmacogenomics Education |
| • Support the inclusion of pharmacogenomics education in pharmacy curricula (e.g., didactic and experiential courses) and residency training programs |
| • Foster the development of pharmacogenomics specialty postgraduate training programs |
| • Develop and disseminate pharmacist-oriented education resources |
| - Update the 2016 ACCP Pharmacotherapy Didactic Curriculum Toolkit (https://www.accp.com/docs/positions/misc/AM_Pharm_Toolkit_2016_revised.pdf) to include “pharmacogenomics considerations” as a tier 1a topic for each disorder that highlights actionable gene-drug pairs |
| - Offer a variety of knowledge-, application-, and practice-based CPE programs, including certificate programs |
| - Update the text of ACCP’s Pharmacogenomics: Applications to Patient Care, when warranted, and consider developing an abbreviated version of the book for home study, knowledge-based CPE credit |
| • Create and disseminate patient education and other health care professional–oriented education resources |
| - Build a resource page on the ACCP website that summarizes pertinent resources and provides links to patient-oriented pharmacogenomics education (e.g., IGNITE) |
| - Create a resource page on the ACCP website that summarizes pertinent resources and provides links to health care professional–oriented pharmacogenomics education (e.g., IGNITE, G2C2) |
| • Engage with other organizations to promote interdisciplinary education models (e.g., NIH/NHGRI Inter-Society Coordinating Committee for Practitioner Education in Genomics) |
| Clinical Pharmacogenomics Research |
| • Advocate research funding and provide grant opportunities for clinical pharmacogenomics research |
| • Recruit mentors and mentees interested in clinical pharmacogenomics research to participate in ACCP’s MeRIT and FIT programs |
| • Support the development of pharmacogenomics-related practice-based research and network studies |
a
Tier 1 = Students receive education and training on this topic to prepare them to provide collaborative, patient-centered care upon graduation and licensure.
CPE = continuing pharmacy education; FIT = Focused Investigator Training; G2C2 = Genetics/Genomics Competency Center; IGNITE = Implementing Genomics in Practice; MeRIT = Mentored Research Investigator Training; NHGRI = National Human Genome Research Institute; NIH = National Institutes of Health.